PCR is a 15+ year old technology. Something new and novel is needed. With all the companies involved in diagnostics I haven't heard of any that have announced deals with other companies. Non announcements are not unusual until deals are struck and something developed. From what I understand the N assay (v) has all the bells and whistles that are being sought. With that being said it's any ones guess. I have seen other pink companies go from the .20s to over 3. in a year. Someone will get this solved and maybe nnlx will be involved.